| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aging | 147 | 2021 | 968 | 12.160 |
Why?
|
| Insulin-Like Growth Factor I | 75 | 2019 | 301 | 9.070 |
Why?
|
| Growth Hormone | 49 | 2022 | 103 | 6.610 |
Why?
|
| Hippocampus | 43 | 2019 | 188 | 4.720 |
Why?
|
| Brain | 40 | 2021 | 741 | 4.430 |
Why?
|
| Oxidative Stress | 40 | 2019 | 668 | 2.940 |
Why?
|
| Rats | 132 | 2016 | 1576 | 2.900 |
Why?
|
| Animals | 207 | 2023 | 10423 | 2.700 |
Why?
|
| Endothelial Cells | 17 | 2021 | 352 | 2.420 |
Why?
|
| Cognition | 11 | 2021 | 324 | 2.270 |
Why?
|
| Cognition Disorders | 16 | 2015 | 184 | 2.150 |
Why?
|
| Peripheral Arterial Disease | 5 | 2017 | 137 | 2.030 |
Why?
|
| Longevity | 20 | 2022 | 134 | 1.960 |
Why?
|
| Male | 145 | 2023 | 13491 | 1.810 |
Why?
|
| Antioxidants | 11 | 2018 | 223 | 1.510 |
Why?
|
| Mice | 57 | 2023 | 4654 | 1.500 |
Why?
|
| Neovascularization, Physiologic | 11 | 2014 | 124 | 1.410 |
Why?
|
| Rats, Inbred F344 | 51 | 2016 | 174 | 1.410 |
Why?
|
| Microvessels | 9 | 2015 | 87 | 1.290 |
Why?
|
| Mice, Inbred C57BL | 38 | 2023 | 1576 | 1.250 |
Why?
|
| Exercise Tolerance | 3 | 2017 | 82 | 1.240 |
Why?
|
| Cerebrovascular Circulation | 13 | 2021 | 220 | 1.230 |
Why?
|
| Inflammation Mediators | 7 | 2017 | 165 | 1.210 |
Why?
|
| Maze Learning | 19 | 2019 | 78 | 1.100 |
Why?
|
| Sex Characteristics | 3 | 2017 | 172 | 1.080 |
Why?
|
| Receptor, IGF Type 1 | 7 | 2021 | 41 | 1.070 |
Why?
|
| Neurovascular Coupling | 8 | 2021 | 154 | 1.030 |
Why?
|
| Cognitive Dysfunction | 8 | 2023 | 263 | 1.010 |
Why?
|
| Rats, Inbred BN | 37 | 2016 | 70 | 0.980 |
Why?
|
| Memory Disorders | 10 | 2012 | 49 | 0.980 |
Why?
|
| Radiation Injuries | 4 | 2020 | 52 | 0.960 |
Why?
|
| Astrocytes | 5 | 2021 | 77 | 0.960 |
Why?
|
| Behavior, Animal | 8 | 2018 | 108 | 0.930 |
Why?
|
| Microcirculation | 9 | 2015 | 112 | 0.930 |
Why?
|
| Bone Density | 2 | 2016 | 100 | 0.930 |
Why?
|
| Signal Transduction | 15 | 2019 | 1435 | 0.930 |
Why?
|
| Disease Models, Animal | 29 | 2019 | 1461 | 0.920 |
Why?
|
| Neurons | 17 | 2021 | 283 | 0.910 |
Why?
|
| Mitochondria | 8 | 2021 | 369 | 0.880 |
Why?
|
| Reactive Oxygen Species | 17 | 2018 | 285 | 0.850 |
Why?
|
| Energy Intake | 11 | 2002 | 69 | 0.850 |
Why?
|
| Apoptosis | 16 | 2018 | 775 | 0.850 |
Why?
|
| Cerebrovascular Disorders | 3 | 2013 | 46 | 0.820 |
Why?
|
| Cerebral Cortex | 11 | 2021 | 134 | 0.810 |
Why?
|
| NF-E2-Related Factor 2 | 11 | 2018 | 122 | 0.800 |
Why?
|
| Synapses | 7 | 2012 | 51 | 0.790 |
Why?
|
| Cellular Senescence | 6 | 2020 | 125 | 0.780 |
Why?
|
| RNA | 4 | 2012 | 110 | 0.780 |
Why?
|
| RNA, Messenger | 19 | 2017 | 659 | 0.780 |
Why?
|
| Amyloid beta-Peptides | 3 | 2018 | 49 | 0.760 |
Why?
|
| Hypertension | 8 | 2017 | 308 | 0.760 |
Why?
|
| Interleukin-6 | 5 | 2020 | 193 | 0.750 |
Why?
|
| Heart | 4 | 2011 | 223 | 0.730 |
Why?
|
| Hypoxia | 3 | 2014 | 89 | 0.730 |
Why?
|
| Female | 49 | 2022 | 15156 | 0.720 |
Why?
|
| Motor Activity | 4 | 2018 | 148 | 0.710 |
Why?
|
| Cells, Cultured | 15 | 2018 | 985 | 0.700 |
Why?
|
| Dwarfism | 10 | 2014 | 27 | 0.700 |
Why?
|
| Gene Expression Regulation | 10 | 2019 | 632 | 0.700 |
Why?
|
| Pregnanolone | 1 | 2020 | 3 | 0.690 |
Why?
|
| Circadian Rhythm | 5 | 2018 | 76 | 0.670 |
Why?
|
| Endothelium, Vascular | 8 | 2021 | 325 | 0.650 |
Why?
|
| Alzheimer Disease | 5 | 2018 | 220 | 0.650 |
Why?
|
| Liver | 12 | 2016 | 440 | 0.650 |
Why?
|
| Time Factors | 17 | 2017 | 1592 | 0.630 |
Why?
|
| DNA Damage | 3 | 2019 | 151 | 0.610 |
Why?
|
| Neuronal Plasticity | 8 | 2018 | 50 | 0.610 |
Why?
|
| Walking | 2 | 2017 | 135 | 0.600 |
Why?
|
| Humans | 44 | 2022 | 28097 | 0.600 |
Why?
|
| Dementia, Vascular | 3 | 2015 | 51 | 0.600 |
Why?
|
| Stilbenes | 7 | 2015 | 90 | 0.590 |
Why?
|
| Biomarkers | 11 | 2019 | 765 | 0.570 |
Why?
|
| Memory, Short-Term | 1 | 2018 | 62 | 0.560 |
Why?
|
| Myocardium | 6 | 2006 | 192 | 0.560 |
Why?
|
| Glucose | 5 | 2018 | 204 | 0.550 |
Why?
|
| Genetic Pleiotropy | 1 | 2017 | 9 | 0.550 |
Why?
|
| DNA Repair | 2 | 2017 | 82 | 0.530 |
Why?
|
| Tibia | 2 | 2016 | 39 | 0.530 |
Why?
|
| Cranial Irradiation | 2 | 2013 | 12 | 0.530 |
Why?
|
| Vascular Endothelial Growth Factor A | 4 | 2014 | 179 | 0.530 |
Why?
|
| Gamma Rays | 3 | 2013 | 27 | 0.520 |
Why?
|
| Rats, Inbred Lew | 11 | 2017 | 34 | 0.520 |
Why?
|
| Memory | 7 | 2015 | 73 | 0.510 |
Why?
|
| Tibial Fractures | 1 | 2016 | 16 | 0.500 |
Why?
|
| Health Status | 1 | 2017 | 148 | 0.500 |
Why?
|
| Exercise Therapy | 1 | 2017 | 84 | 0.500 |
Why?
|
| Models, Animal | 8 | 2018 | 129 | 0.500 |
Why?
|
| Brain Injuries | 2 | 2014 | 49 | 0.500 |
Why?
|
| Inflammation | 12 | 2018 | 636 | 0.500 |
Why?
|
| Chronic Disease | 2 | 2016 | 271 | 0.490 |
Why?
|
| Mice, Transgenic | 8 | 2019 | 507 | 0.480 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2017 | 123 | 0.470 |
Why?
|
| Angiotensin II | 6 | 2017 | 55 | 0.470 |
Why?
|
| Cytokines | 11 | 2020 | 447 | 0.470 |
Why?
|
| Exercise Test | 4 | 2017 | 248 | 0.460 |
Why?
|
| Spine | 1 | 2015 | 61 | 0.460 |
Why?
|
| Endothelin-1 | 1 | 2014 | 10 | 0.460 |
Why?
|
| Whole-Body Irradiation | 1 | 2014 | 40 | 0.450 |
Why?
|
| Aged | 10 | 2019 | 5400 | 0.440 |
Why?
|
| Stem Cells | 2 | 2014 | 121 | 0.440 |
Why?
|
| Lower Extremity | 1 | 2015 | 84 | 0.440 |
Why?
|
| NF-kappa B | 8 | 2017 | 191 | 0.440 |
Why?
|
| Somatostatin | 8 | 1995 | 25 | 0.440 |
Why?
|
| Oxygen | 4 | 2012 | 233 | 0.430 |
Why?
|
| Somatosensory Cortex | 5 | 2015 | 17 | 0.430 |
Why?
|
| Growth Hormone-Releasing Hormone | 6 | 2000 | 10 | 0.430 |
Why?
|
| Models, Biological | 5 | 2014 | 466 | 0.420 |
Why?
|
| Cell Physiological Phenomena | 1 | 2013 | 7 | 0.420 |
Why?
|
| Diastole | 3 | 2011 | 22 | 0.420 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 5 | 2014 | 15 | 0.420 |
Why?
|
| Brain Ischemia | 1 | 2014 | 85 | 0.420 |
Why?
|
| Caloric Restriction | 7 | 2014 | 73 | 0.400 |
Why?
|
| Aldehydes | 2 | 2019 | 55 | 0.400 |
Why?
|
| Ethanol | 5 | 1995 | 123 | 0.400 |
Why?
|
| Mammary Neoplasms, Experimental | 3 | 2019 | 48 | 0.390 |
Why?
|
| Spatial Behavior | 2 | 2004 | 3 | 0.390 |
Why?
|
| MicroRNAs | 4 | 2020 | 301 | 0.390 |
Why?
|
| Middle Cerebral Artery | 5 | 2015 | 48 | 0.380 |
Why?
|
| Receptor, Insulin | 4 | 2015 | 93 | 0.380 |
Why?
|
| Protein Biosynthesis | 6 | 1999 | 111 | 0.370 |
Why?
|
| Hypothalamus | 13 | 2009 | 29 | 0.370 |
Why?
|
| Obesity | 5 | 2018 | 669 | 0.370 |
Why?
|
| African Americans | 1 | 2014 | 352 | 0.370 |
Why?
|
| Proteome | 2 | 2010 | 77 | 0.370 |
Why?
|
| Somatomedins | 5 | 2011 | 18 | 0.370 |
Why?
|
| Age Factors | 18 | 2019 | 734 | 0.370 |
Why?
|
| Gene Expression | 11 | 2018 | 417 | 0.370 |
Why?
|
| Listeriosis | 2 | 2023 | 41 | 0.370 |
Why?
|
| Biochemistry | 1 | 2011 | 10 | 0.360 |
Why?
|
| Molecular Probes | 1 | 2011 | 13 | 0.360 |
Why?
|
| Cerebral Arteries | 5 | 2015 | 33 | 0.360 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 2 | 2019 | 15 | 0.360 |
Why?
|
| Oxidation-Reduction | 9 | 2017 | 365 | 0.360 |
Why?
|
| Physical Conditioning, Animal | 2 | 2008 | 38 | 0.350 |
Why?
|
| Biotin | 1 | 2010 | 25 | 0.350 |
Why?
|
| Biological Assay | 1 | 2010 | 34 | 0.350 |
Why?
|
| Proteins | 5 | 2013 | 252 | 0.350 |
Why?
|
| Myocardial Contraction | 2 | 2008 | 62 | 0.340 |
Why?
|
| Rats, Mutant Strains | 7 | 2014 | 16 | 0.340 |
Why?
|
| Aorta | 5 | 2016 | 124 | 0.340 |
Why?
|
| Nerve Tissue Proteins | 6 | 2013 | 153 | 0.340 |
Why?
|
| Receptors, Somatotropin | 3 | 1996 | 3 | 0.330 |
Why?
|
| Blood Vessels | 5 | 2010 | 59 | 0.330 |
Why?
|
| Hypercapnia | 1 | 2009 | 5 | 0.320 |
Why?
|
| Human Growth Hormone | 2 | 2022 | 15 | 0.320 |
Why?
|
| Depression | 1 | 2011 | 216 | 0.310 |
Why?
|
| Myelin Proteins | 3 | 2013 | 13 | 0.300 |
Why?
|
| Disease | 1 | 2008 | 15 | 0.300 |
Why?
|
| Motor Cortex | 4 | 2021 | 48 | 0.300 |
Why?
|
| Learning | 4 | 2013 | 97 | 0.290 |
Why?
|
| Body Weight | 14 | 2014 | 250 | 0.290 |
Why?
|
| Dwarfism, Pituitary | 2 | 2022 | 4 | 0.290 |
Why?
|
| Middle Aged | 6 | 2019 | 7138 | 0.290 |
Why?
|
| Muscle, Smooth, Vascular | 4 | 2018 | 77 | 0.280 |
Why?
|
| Space Perception | 3 | 2008 | 8 | 0.280 |
Why?
|
| Dentate Gyrus | 6 | 2014 | 9 | 0.280 |
Why?
|
| Carrier Proteins | 4 | 1993 | 252 | 0.270 |
Why?
|
| Muscle Contraction | 3 | 2018 | 170 | 0.270 |
Why?
|
| Diet, High-Fat | 5 | 2018 | 137 | 0.260 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 4 | 2012 | 37 | 0.260 |
Why?
|
| Phenotype | 8 | 2021 | 681 | 0.260 |
Why?
|
| Hormone Replacement Therapy | 1 | 2006 | 9 | 0.250 |
Why?
|
| Blood-Brain Barrier | 6 | 2018 | 83 | 0.250 |
Why?
|
| Fibroblasts | 5 | 2017 | 157 | 0.250 |
Why?
|
| Glutathione Disulfide | 1 | 2005 | 14 | 0.250 |
Why?
|
| Adenosine Triphosphate | 1 | 2006 | 118 | 0.250 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2006 | 64 | 0.240 |
Why?
|
| Caenorhabditis elegans Proteins | 2 | 2002 | 57 | 0.240 |
Why?
|
| Cell Proliferation | 7 | 2014 | 806 | 0.240 |
Why?
|
| Steroid Metabolism, Inborn Errors | 1 | 2005 | 1 | 0.240 |
Why?
|
| Proto-Oncogene Proteins | 2 | 1996 | 140 | 0.240 |
Why?
|
| Hydroxyeicosatetraenoic Acids | 3 | 2013 | 16 | 0.240 |
Why?
|
| Receptors, Cell Surface | 3 | 2013 | 114 | 0.240 |
Why?
|
| Up-Regulation | 7 | 2017 | 246 | 0.240 |
Why?
|
| Osteoarthritis, Knee | 2 | 2006 | 25 | 0.230 |
Why?
|
| Sleep Deprivation | 2 | 2021 | 28 | 0.230 |
Why?
|
| Rats, Sprague-Dawley | 8 | 2019 | 551 | 0.230 |
Why?
|
| Life Expectancy | 2 | 2012 | 23 | 0.230 |
Why?
|
| Arterioles | 3 | 2018 | 61 | 0.220 |
Why?
|
| Vasoconstriction | 2 | 2015 | 45 | 0.220 |
Why?
|
| Neoplasms | 3 | 2017 | 809 | 0.220 |
Why?
|
| Spectroscopy, Near-Infrared | 2 | 2021 | 74 | 0.220 |
Why?
|
| Major Histocompatibility Complex | 2 | 2016 | 28 | 0.220 |
Why?
|
| Risk Factors | 5 | 2014 | 2081 | 0.220 |
Why?
|
| Green Fluorescent Proteins | 3 | 2014 | 101 | 0.220 |
Why?
|
| Microglia | 4 | 2017 | 64 | 0.220 |
Why?
|
| Tumor Necrosis Factor-alpha | 6 | 2017 | 247 | 0.210 |
Why?
|
| Predictive Value of Tests | 3 | 2019 | 474 | 0.210 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2023 | 97 | 0.210 |
Why?
|
| Mice, Knockout | 8 | 2019 | 848 | 0.210 |
Why?
|
| Adaptation, Physiological | 3 | 2015 | 169 | 0.210 |
Why?
|
| Muscle, Skeletal | 5 | 2014 | 634 | 0.210 |
Why?
|
| Swimming | 5 | 2011 | 32 | 0.210 |
Why?
|
| Hemodynamics | 2 | 2021 | 220 | 0.200 |
Why?
|
| Mercenaria | 2 | 2013 | 6 | 0.200 |
Why?
|
| Analysis of Variance | 8 | 2016 | 391 | 0.200 |
Why?
|
| Listeria monocytogenes | 1 | 2023 | 59 | 0.200 |
Why?
|
| Transcriptome | 5 | 2017 | 214 | 0.200 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 1994 | 110 | 0.200 |
Why?
|
| Carcinogens | 1 | 2002 | 39 | 0.200 |
Why?
|
| Diet | 4 | 1997 | 232 | 0.200 |
Why?
|
| Body Composition | 4 | 2011 | 265 | 0.190 |
Why?
|
| Long-Term Potentiation | 2 | 2012 | 4 | 0.190 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2002 | 23 | 0.190 |
Why?
|
| Capillaries | 2 | 2001 | 33 | 0.190 |
Why?
|
| tert-Butylhydroperoxide | 2 | 2012 | 7 | 0.190 |
Why?
|
| Pituitary Gland | 6 | 1989 | 53 | 0.190 |
Why?
|
| NADPH Oxidases | 3 | 2017 | 69 | 0.190 |
Why?
|
| Radioimmunoassay | 8 | 2004 | 45 | 0.190 |
Why?
|
| Coronary Vessels | 3 | 2012 | 152 | 0.190 |
Why?
|
| Cell Adhesion | 4 | 2014 | 138 | 0.180 |
Why?
|
| Coronary Circulation | 1 | 2001 | 30 | 0.180 |
Why?
|
| Nerve Regeneration | 3 | 2010 | 12 | 0.180 |
Why?
|
| Homeostasis | 4 | 2015 | 118 | 0.180 |
Why?
|
| Spatial Memory | 2 | 2018 | 15 | 0.180 |
Why?
|
| Capillary Permeability | 1 | 2001 | 53 | 0.180 |
Why?
|
| Insulin-Like Growth Factor II | 3 | 1995 | 19 | 0.180 |
Why?
|
| Carotid Arteries | 2 | 2011 | 54 | 0.180 |
Why?
|
| Transfection | 3 | 2017 | 318 | 0.170 |
Why?
|
| Synaptic Transmission | 3 | 2011 | 49 | 0.170 |
Why?
|
| Reversal Learning | 2 | 2018 | 8 | 0.170 |
Why?
|
| Chondrocytes | 1 | 2000 | 27 | 0.170 |
Why?
|
| HeLa Cells | 2 | 2011 | 208 | 0.170 |
Why?
|
| Retina | 2 | 2017 | 436 | 0.170 |
Why?
|
| Mammals | 1 | 2000 | 48 | 0.170 |
Why?
|
| Rats, Inbred Strains | 12 | 2002 | 63 | 0.170 |
Why?
|
| Immunologic Memory | 1 | 2020 | 58 | 0.170 |
Why?
|
| Cell Division | 6 | 2001 | 154 | 0.170 |
Why?
|
| Dose-Response Relationship, Drug | 7 | 2011 | 607 | 0.160 |
Why?
|
| Diet, Reducing | 2 | 1996 | 10 | 0.160 |
Why?
|
| Adipose Tissue | 3 | 2012 | 183 | 0.160 |
Why?
|
| TRPC Cation Channels | 3 | 2014 | 34 | 0.160 |
Why?
|
| Sex Factors | 3 | 2019 | 466 | 0.160 |
Why?
|
| Psychomotor Disorders | 1 | 2019 | 5 | 0.160 |
Why?
|
| Blood Pressure | 5 | 2015 | 354 | 0.160 |
Why?
|
| Pharmaceutical Preparations | 1 | 2020 | 46 | 0.160 |
Why?
|
| Blood Glucose | 5 | 2014 | 309 | 0.160 |
Why?
|
| Cell Culture Techniques | 2 | 2017 | 116 | 0.160 |
Why?
|
| Autoradiography | 7 | 2011 | 28 | 0.160 |
Why?
|
| Pituitary Gland, Anterior | 4 | 1991 | 30 | 0.160 |
Why?
|
| Hydrogen Peroxide | 7 | 2012 | 144 | 0.150 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 302 | 0.150 |
Why?
|
| Transcription Factors | 1 | 2002 | 520 | 0.150 |
Why?
|
| Vascular Stiffness | 1 | 2019 | 41 | 0.150 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2019 | 64 | 0.150 |
Why?
|
| Membrane Glycoproteins | 2 | 2017 | 145 | 0.150 |
Why?
|
| Transcription, Genetic | 6 | 2016 | 403 | 0.150 |
Why?
|
| Retinal Artery | 1 | 2018 | 11 | 0.150 |
Why?
|
| C-Reactive Protein | 2 | 2017 | 92 | 0.150 |
Why?
|
| Extracellular Matrix | 2 | 2017 | 117 | 0.150 |
Why?
|
| Fetal Alcohol Spectrum Disorders | 2 | 1995 | 12 | 0.150 |
Why?
|
| Activities of Daily Living | 2 | 2014 | 106 | 0.150 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2011 | 328 | 0.150 |
Why?
|
| Confidence Intervals | 1 | 2018 | 68 | 0.150 |
Why?
|
| Cell Nucleus | 2 | 2009 | 138 | 0.140 |
Why?
|
| Myocytes, Smooth Muscle | 3 | 2015 | 38 | 0.140 |
Why?
|
| Gene Expression Profiling | 3 | 2017 | 453 | 0.140 |
Why?
|
| Caveolin 1 | 1 | 2018 | 43 | 0.140 |
Why?
|
| Oklahoma | 2 | 2021 | 1007 | 0.140 |
Why?
|
| DNA | 5 | 2016 | 374 | 0.140 |
Why?
|
| Odds Ratio | 1 | 2018 | 236 | 0.140 |
Why?
|
| Growth | 2 | 2011 | 24 | 0.140 |
Why?
|
| Receptors, Somatomedin | 2 | 1994 | 4 | 0.140 |
Why?
|
| Receptor, IGF Type 2 | 3 | 1996 | 6 | 0.140 |
Why?
|
| Hydroxyl Radical | 1 | 2017 | 7 | 0.140 |
Why?
|
| Insulin | 5 | 2012 | 315 | 0.140 |
Why?
|
| Fitness Trackers | 1 | 2017 | 10 | 0.140 |
Why?
|
| Actigraphy | 1 | 2017 | 22 | 0.140 |
Why?
|
| In Vitro Techniques | 7 | 2011 | 241 | 0.140 |
Why?
|
| Phosphatidylethanolamines | 1 | 2017 | 26 | 0.130 |
Why?
|
| Phosphatidylserines | 1 | 2017 | 20 | 0.130 |
Why?
|
| Prospective Studies | 2 | 2019 | 1248 | 0.130 |
Why?
|
| Ankle Brachial Index | 1 | 2017 | 34 | 0.130 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2013 | 257 | 0.130 |
Why?
|
| Phosphatidylcholines | 1 | 2017 | 45 | 0.130 |
Why?
|
| Vascular Diseases | 3 | 2012 | 68 | 0.130 |
Why?
|
| Community Health Services | 1 | 2017 | 32 | 0.130 |
Why?
|
| Peptides | 2 | 2018 | 288 | 0.130 |
Why?
|
| Neurites | 1 | 2016 | 10 | 0.130 |
Why?
|
| Peripheral Nerve Injuries | 1 | 2016 | 2 | 0.130 |
Why?
|
| Synaptosomes | 3 | 2012 | 9 | 0.130 |
Why?
|
| Receptor, trkA | 1 | 2016 | 10 | 0.130 |
Why?
|
| Neocortex | 1 | 2016 | 8 | 0.130 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2016 | 3 | 0.130 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2016 | 20 | 0.130 |
Why?
|
| Microvascular Rarefaction | 1 | 2016 | 13 | 0.130 |
Why?
|
| Exploratory Behavior | 2 | 2011 | 12 | 0.130 |
Why?
|
| 5-Methylcytosine | 1 | 2016 | 3 | 0.130 |
Why?
|
| Sulfites | 1 | 2016 | 8 | 0.130 |
Why?
|
| Cerebral Hemorrhage | 1 | 2017 | 91 | 0.130 |
Why?
|
| CA1 Region, Hippocampal | 2 | 2014 | 7 | 0.130 |
Why?
|
| Hyperglycemia | 3 | 2011 | 78 | 0.130 |
Why?
|
| Trans-Activators | 1 | 1996 | 118 | 0.130 |
Why?
|
| X-Ray Microtomography | 1 | 2016 | 32 | 0.130 |
Why?
|
| Early Medical Intervention | 1 | 2015 | 7 | 0.130 |
Why?
|
| Receptors, Purinergic P2Y1 | 1 | 2015 | 4 | 0.120 |
Why?
|
| Early Diagnosis | 1 | 2015 | 32 | 0.120 |
Why?
|
| Bivalvia | 2 | 2012 | 20 | 0.120 |
Why?
|
| RANK Ligand | 1 | 2015 | 19 | 0.120 |
Why?
|
| Biomedical Research | 1 | 2016 | 97 | 0.120 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2015 | 55 | 0.120 |
Why?
|
| Vasodilation | 2 | 2013 | 114 | 0.120 |
Why?
|
| Subcellular Fractions | 1 | 1995 | 20 | 0.120 |
Why?
|
| Reaction Time | 2 | 2021 | 94 | 0.120 |
Why?
|
| Pulsatile Flow | 1 | 2015 | 9 | 0.120 |
Why?
|
| Muscles | 2 | 1993 | 73 | 0.120 |
Why?
|
| Hyperemia | 1 | 2015 | 40 | 0.120 |
Why?
|
| Radiation Injuries, Experimental | 2 | 2012 | 31 | 0.120 |
Why?
|
| Membrane Proteins | 4 | 2013 | 484 | 0.120 |
Why?
|
| Cell Communication | 1 | 2015 | 68 | 0.120 |
Why?
|
| Osteoporosis | 1 | 2015 | 63 | 0.120 |
Why?
|
| Hand Strength | 3 | 2015 | 38 | 0.120 |
Why?
|
| Intracranial Hemorrhages | 1 | 2015 | 30 | 0.120 |
Why?
|
| Biological Evolution | 3 | 2012 | 99 | 0.120 |
Why?
|
| Chemokine CCL2 | 4 | 2019 | 47 | 0.120 |
Why?
|
| Neuroglia | 3 | 2011 | 30 | 0.120 |
Why?
|
| Pituitary Adenylate Cyclase-Activating Polypeptide | 1 | 2014 | 7 | 0.110 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2013 | 66 | 0.110 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2014 | 8 | 0.110 |
Why?
|
| Models, Neurological | 1 | 2014 | 32 | 0.110 |
Why?
|
| Brain Edema | 1 | 2014 | 21 | 0.110 |
Why?
|
| Epigenesis, Genetic | 1 | 2016 | 147 | 0.110 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2014 | 6 | 0.110 |
Why?
|
| Stem Cell Niche | 1 | 2014 | 12 | 0.110 |
Why?
|
| Arthritis, Experimental | 1 | 2014 | 6 | 0.110 |
Why?
|
| Apurinic Acid | 2 | 2012 | 2 | 0.110 |
Why?
|
| Guanosine | 2 | 2012 | 5 | 0.110 |
Why?
|
| Cerebral Infarction | 1 | 2014 | 26 | 0.110 |
Why?
|
| Carbon Dioxide | 2 | 2009 | 92 | 0.110 |
Why?
|
| Hemoglobinometry | 1 | 2014 | 5 | 0.110 |
Why?
|
| Actins | 2 | 2013 | 96 | 0.110 |
Why?
|
| Bone Marrow Transplantation | 1 | 2014 | 49 | 0.110 |
Why?
|
| Cell Count | 6 | 2006 | 86 | 0.110 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2014 | 22 | 0.110 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 5 | 2011 | 40 | 0.110 |
Why?
|
| Osteoarthritis | 1 | 2014 | 36 | 0.110 |
Why?
|
| Interleukin-10 | 1 | 2014 | 72 | 0.110 |
Why?
|
| Excitatory Postsynaptic Potentials | 2 | 2011 | 7 | 0.110 |
Why?
|
| Mitochondria, Heart | 1 | 2013 | 23 | 0.110 |
Why?
|
| Superoxide Dismutase | 2 | 2012 | 71 | 0.110 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2014 | 39 | 0.110 |
Why?
|
| Cerebrum | 1 | 2013 | 14 | 0.110 |
Why?
|
| Heterozygote | 2 | 2005 | 65 | 0.110 |
Why?
|
| Regional Blood Flow | 1 | 2015 | 163 | 0.110 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 1 | 2013 | 4 | 0.110 |
Why?
|
| Heat-Shock Proteins | 1 | 2013 | 38 | 0.110 |
Why?
|
| Temperature | 2 | 2012 | 213 | 0.110 |
Why?
|
| Interleukin-8 | 1 | 2013 | 44 | 0.110 |
Why?
|
| Genetic Vectors | 2 | 2011 | 116 | 0.110 |
Why?
|
| Genes, p16 | 1 | 2013 | 7 | 0.110 |
Why?
|
| Luteinizing Hormone | 5 | 1985 | 57 | 0.110 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2013 | 80 | 0.110 |
Why?
|
| Secretory Pathway | 1 | 2013 | 6 | 0.100 |
Why?
|
| beta-Galactosidase | 1 | 2013 | 24 | 0.100 |
Why?
|
| Reference Values | 3 | 2002 | 199 | 0.100 |
Why?
|
| Vasomotor System | 1 | 2013 | 8 | 0.100 |
Why?
|
| Tibial Nerve | 2 | 2010 | 2 | 0.100 |
Why?
|
| Amidines | 1 | 2013 | 8 | 0.100 |
Why?
|
| Prognosis | 1 | 2015 | 803 | 0.100 |
Why?
|
| Calcium Signaling | 1 | 2013 | 72 | 0.100 |
Why?
|
| DNA-Binding Proteins | 1 | 1996 | 490 | 0.100 |
Why?
|
| Muscle Proteins | 2 | 2000 | 56 | 0.100 |
Why?
|
| Ribonuclease III | 1 | 2012 | 6 | 0.100 |
Why?
|
| Growth Disorders | 1 | 1993 | 21 | 0.100 |
Why?
|
| Protein Carbonylation | 1 | 2012 | 6 | 0.100 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2012 | 26 | 0.100 |
Why?
|
| Shock, Septic | 1 | 2012 | 38 | 0.100 |
Why?
|
| ADAM Proteins | 1 | 2013 | 103 | 0.100 |
Why?
|
| Neuromuscular Junction | 2 | 2010 | 22 | 0.100 |
Why?
|
| Tissue Culture Techniques | 4 | 2015 | 31 | 0.100 |
Why?
|
| Cytochromes c | 1 | 2012 | 13 | 0.100 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 2 | 2010 | 40 | 0.100 |
Why?
|
| Histocompatibility Antigens | 1 | 2012 | 8 | 0.100 |
Why?
|
| Collagen Type IV | 1 | 2012 | 6 | 0.100 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-2 | 1 | 2012 | 9 | 0.100 |
Why?
|
| Caenorhabditis elegans | 2 | 2002 | 61 | 0.100 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2012 | 40 | 0.100 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 3 | 1996 | 31 | 0.100 |
Why?
|
| Promoter Regions, Genetic | 2 | 2010 | 343 | 0.100 |
Why?
|
| Electroshock | 1 | 1991 | 6 | 0.100 |
Why?
|
| Genes, fos | 1 | 1991 | 13 | 0.100 |
Why?
|
| Brain Chemistry | 1 | 1991 | 22 | 0.090 |
Why?
|
| Bacteremia | 1 | 2012 | 80 | 0.090 |
Why?
|
| Receptor, Muscarinic M4 | 1 | 2011 | 1 | 0.090 |
Why?
|
| Primates | 1 | 2012 | 22 | 0.090 |
Why?
|
| Receptor, TIE-2 | 1 | 2011 | 8 | 0.090 |
Why?
|
| Mitochondrial Proteins | 1 | 2012 | 74 | 0.090 |
Why?
|
| Receptor, Muscarinic M2 | 1 | 2011 | 15 | 0.090 |
Why?
|
| Angiopoietin-2 | 1 | 2011 | 10 | 0.090 |
Why?
|
| Patch-Clamp Techniques | 3 | 2011 | 31 | 0.090 |
Why?
|
| Receptors, Immunologic | 1 | 2012 | 72 | 0.090 |
Why?
|
| Angiopoietin-1 | 1 | 2011 | 8 | 0.090 |
Why?
|
| GTP-Binding Proteins | 1 | 2011 | 46 | 0.090 |
Why?
|
| Corpus Striatum | 1 | 2011 | 23 | 0.090 |
Why?
|
| Seizures | 1 | 1991 | 48 | 0.090 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2012 | 64 | 0.090 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2011 | 58 | 0.090 |
Why?
|
| Streptavidin | 1 | 2011 | 11 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2021 | 819 | 0.090 |
Why?
|
| Hindlimb Suspension | 1 | 2011 | 8 | 0.090 |
Why?
|
| Inhibitor of Differentiation Proteins | 1 | 2011 | 11 | 0.090 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2012 | 77 | 0.090 |
Why?
|
| Presynaptic Terminals | 1 | 2011 | 21 | 0.090 |
Why?
|
| Glutamate-Cysteine Ligase | 4 | 2011 | 25 | 0.090 |
Why?
|
| Echocardiography, Doppler | 1 | 2011 | 21 | 0.090 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2012 | 120 | 0.090 |
Why?
|
| Mass Spectrometry | 2 | 2010 | 191 | 0.090 |
Why?
|
| Free Radicals | 1 | 2011 | 39 | 0.090 |
Why?
|
| Polynucleotides | 1 | 2010 | 1 | 0.090 |
Why?
|
| Peroxynitrous Acid | 1 | 2010 | 7 | 0.090 |
Why?
|
| Quantitative Structure-Activity Relationship | 1 | 2010 | 5 | 0.090 |
Why?
|
| Microspheres | 1 | 2011 | 49 | 0.090 |
Why?
|
| Receptors, Endothelin | 1 | 2010 | 2 | 0.090 |
Why?
|
| Peptide Fragments | 2 | 2000 | 202 | 0.090 |
Why?
|
| Reactive Nitrogen Species | 1 | 2010 | 10 | 0.090 |
Why?
|
| Anaerobiosis | 1 | 2010 | 91 | 0.090 |
Why?
|
| Glucuronidase | 1 | 2010 | 9 | 0.090 |
Why?
|
| Organ Specificity | 3 | 2006 | 82 | 0.090 |
Why?
|
| Linear Models | 1 | 2011 | 202 | 0.090 |
Why?
|
| Food Deprivation | 4 | 2011 | 11 | 0.090 |
Why?
|
| Superoxides | 1 | 2010 | 62 | 0.090 |
Why?
|
| Treatment Outcome | 1 | 2017 | 2379 | 0.090 |
Why?
|
| Cartilage, Articular | 3 | 2014 | 44 | 0.080 |
Why?
|
| Adult | 3 | 2021 | 7740 | 0.080 |
Why?
|
| Kidney Diseases | 1 | 2010 | 61 | 0.080 |
Why?
|
| Adrenocorticotropic Hormone | 2 | 1987 | 17 | 0.080 |
Why?
|
| Down-Regulation | 3 | 2016 | 199 | 0.080 |
Why?
|
| Geriatrics | 2 | 2019 | 47 | 0.080 |
Why?
|
| Corticosterone | 2 | 1987 | 34 | 0.080 |
Why?
|
| Mice, Inbred ICR | 3 | 2018 | 26 | 0.080 |
Why?
|
| Ependyma | 1 | 2009 | 3 | 0.080 |
Why?
|
| Pregnancy | 8 | 1995 | 1191 | 0.080 |
Why?
|
| Corpus Callosum | 1 | 2009 | 20 | 0.080 |
Why?
|
| Oligodendroglia | 1 | 2009 | 15 | 0.080 |
Why?
|
| Nitric Oxide | 3 | 2015 | 152 | 0.080 |
Why?
|
| Transduction, Genetic | 1 | 2009 | 27 | 0.080 |
Why?
|
| Urinary Bladder | 1 | 2010 | 119 | 0.080 |
Why?
|
| Trauma, Nervous System | 1 | 2009 | 2 | 0.080 |
Why?
|
| Immunohistochemistry | 3 | 2006 | 463 | 0.080 |
Why?
|
| Enzyme Inhibitors | 4 | 2015 | 250 | 0.080 |
Why?
|
| Gene Transfer Techniques | 1 | 2009 | 67 | 0.080 |
Why?
|
| Interleukin-1beta | 3 | 2019 | 45 | 0.080 |
Why?
|
| Stochastic Processes | 1 | 2008 | 10 | 0.080 |
Why?
|
| Case-Control Studies | 2 | 2021 | 722 | 0.080 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2008 | 18 | 0.080 |
Why?
|
| Homozygote | 2 | 2005 | 36 | 0.070 |
Why?
|
| Levodopa | 3 | 1985 | 10 | 0.070 |
Why?
|
| In Situ Hybridization | 3 | 1998 | 34 | 0.070 |
Why?
|
| Immunoblotting | 2 | 2004 | 124 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 3 | 2014 | 134 | 0.070 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 2021 | 0.070 |
Why?
|
| Injections, Intraventricular | 3 | 2009 | 7 | 0.070 |
Why?
|
| Genetic Therapy | 1 | 2009 | 123 | 0.070 |
Why?
|
| Psychomotor Performance | 2 | 2017 | 72 | 0.070 |
Why?
|
| Receptors, Glutamate | 1 | 2008 | 3 | 0.070 |
Why?
|
| Echocardiography | 1 | 2008 | 108 | 0.070 |
Why?
|
| Child | 1 | 2014 | 2242 | 0.070 |
Why?
|
| Crosses, Genetic | 2 | 2014 | 36 | 0.070 |
Why?
|
| Macaca mulatta | 3 | 2012 | 50 | 0.070 |
Why?
|
| Alcoholism | 1 | 1989 | 119 | 0.070 |
Why?
|
| Intercellular Adhesion Molecule-1 | 3 | 2012 | 58 | 0.070 |
Why?
|
| Brain Mapping | 2 | 2021 | 201 | 0.070 |
Why?
|
| Cell Survival | 3 | 2009 | 409 | 0.070 |
Why?
|
| Testosterone | 4 | 1985 | 72 | 0.070 |
Why?
|
| Neuropsychological Tests | 1 | 2008 | 243 | 0.070 |
Why?
|
| Neurotransmitter Agents | 2 | 1991 | 21 | 0.070 |
Why?
|
| Amino Acid Sequence | 1 | 2008 | 692 | 0.070 |
Why?
|
| Penicillamine | 2 | 1977 | 9 | 0.070 |
Why?
|
| Stifle | 1 | 2006 | 1 | 0.070 |
Why?
|
| Adolescent | 1 | 2014 | 3122 | 0.070 |
Why?
|
| Animals, Newborn | 4 | 2006 | 180 | 0.070 |
Why?
|
| Cell Movement | 3 | 2014 | 373 | 0.070 |
Why?
|
| Stroke | 1 | 2010 | 252 | 0.070 |
Why?
|
| Heme Oxygenase-1 | 3 | 2011 | 36 | 0.070 |
Why?
|
| Glucose Transporter Type 3 | 1 | 2006 | 2 | 0.060 |
Why?
|
| NG-Nitroarginine Methyl Ester | 2 | 2017 | 31 | 0.060 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2006 | 15 | 0.060 |
Why?
|
| Endorphins | 5 | 1985 | 5 | 0.060 |
Why?
|
| Phosphorylation | 3 | 1997 | 578 | 0.060 |
Why?
|
| Organogenesis | 1 | 2006 | 12 | 0.060 |
Why?
|
| Cardiovascular Diseases | 1 | 2010 | 366 | 0.060 |
Why?
|
| Janus Kinase 2 | 2 | 1996 | 36 | 0.060 |
Why?
|
| Gait | 2 | 2017 | 61 | 0.060 |
Why?
|
| Angiotensinogen | 1 | 2005 | 2 | 0.060 |
Why?
|
| Glutathione Reductase | 1 | 2005 | 22 | 0.060 |
Why?
|
| Dendrites | 1 | 2005 | 17 | 0.060 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 1996 | 97 | 0.060 |
Why?
|
| Renin-Angiotensin System | 1 | 2005 | 18 | 0.060 |
Why?
|
| Tissue Distribution | 2 | 1998 | 137 | 0.060 |
Why?
|
| Metals | 1 | 2005 | 41 | 0.060 |
Why?
|
| Hybridization, Genetic | 2 | 2011 | 18 | 0.060 |
Why?
|
| Glutathione | 1 | 2005 | 76 | 0.060 |
Why?
|
| Dietary Fats | 3 | 2011 | 59 | 0.060 |
Why?
|
| Body Temperature | 1 | 2005 | 30 | 0.060 |
Why?
|
| Collagen | 5 | 1995 | 156 | 0.060 |
Why?
|
| NADPH Oxidase 2 | 2 | 2017 | 6 | 0.060 |
Why?
|
| Reproduction | 1 | 2005 | 63 | 0.060 |
Why?
|
| Calcium | 2 | 2013 | 235 | 0.060 |
Why?
|
| Electric Stimulation | 3 | 2011 | 255 | 0.060 |
Why?
|
| Cerebral Ventricles | 2 | 2002 | 17 | 0.060 |
Why?
|
| Enalapril | 1 | 2004 | 1 | 0.060 |
Why?
|
| Infusions, Parenteral | 2 | 2002 | 37 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2017 | 94 | 0.060 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2004 | 32 | 0.060 |
Why?
|
| Cytochrome P-450 Enzyme System | 2 | 2015 | 33 | 0.060 |
Why?
|
| Glutamate Decarboxylase | 1 | 2004 | 7 | 0.050 |
Why?
|
| Receptors, GABA-A | 1 | 2004 | 18 | 0.050 |
Why?
|
| Organ Culture Techniques | 1 | 2004 | 56 | 0.050 |
Why?
|
| Recombinant Proteins | 3 | 2014 | 413 | 0.050 |
Why?
|
| Isoenzymes | 1 | 2004 | 86 | 0.050 |
Why?
|
| Caspase 3 | 2 | 2014 | 58 | 0.050 |
Why?
|
| Amyloid Precursor Protein Secretases | 2 | 2013 | 25 | 0.050 |
Why?
|
| Cattle | 2 | 2012 | 388 | 0.050 |
Why?
|
| Random Allocation | 2 | 2019 | 151 | 0.050 |
Why?
|
| Research | 2 | 2019 | 92 | 0.050 |
Why?
|
| Motion Pictures | 1 | 2022 | 4 | 0.050 |
Why?
|
| Diptera | 1 | 2002 | 7 | 0.050 |
Why?
|
| Computational Biology | 2 | 2017 | 155 | 0.050 |
Why?
|
| Nogo Proteins | 2 | 2013 | 2 | 0.050 |
Why?
|
| Forkhead Transcription Factors | 1 | 2002 | 35 | 0.050 |
Why?
|
| Immune Sera | 2 | 1983 | 22 | 0.050 |
Why?
|
| Diaphragm | 3 | 1997 | 15 | 0.050 |
Why?
|
| Castration | 5 | 1985 | 10 | 0.050 |
Why?
|
| Liposomes | 2 | 2014 | 145 | 0.050 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2021 | 11 | 0.050 |
Why?
|
| Species Specificity | 2 | 2012 | 192 | 0.050 |
Why?
|
| Oxidants | 2 | 2012 | 31 | 0.050 |
Why?
|
| Biology | 1 | 2021 | 14 | 0.050 |
Why?
|
| Nitric Oxide Synthase | 2 | 2012 | 34 | 0.050 |
Why?
|
| Catalase | 2 | 2012 | 49 | 0.050 |
Why?
|
| Ascorbic Acid | 2 | 2012 | 24 | 0.050 |
Why?
|
| Monosaccharide Transport Proteins | 2 | 2000 | 23 | 0.050 |
Why?
|
| Disabled Persons | 1 | 2001 | 18 | 0.050 |
Why?
|
| Probability | 1 | 2001 | 78 | 0.050 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2001 | 58 | 0.050 |
Why?
|
| Hypothalamic Hormones | 1 | 1981 | 1 | 0.040 |
Why?
|
| Pituitary Hormones | 1 | 1981 | 4 | 0.040 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2012 | 54 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2013 | 163 | 0.040 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 2 | 2011 | 15 | 0.040 |
Why?
|
| Neuropil | 1 | 2000 | 2 | 0.040 |
Why?
|
| Macaca fascicularis | 1 | 2000 | 45 | 0.040 |
Why?
|
| Ampicillin | 1 | 2020 | 14 | 0.040 |
Why?
|
| Pregnancy, Animal | 1 | 1980 | 12 | 0.040 |
Why?
|
| Radioligand Assay | 1 | 2000 | 16 | 0.040 |
Why?
|
| Membrane Lipids | 1 | 2000 | 22 | 0.040 |
Why?
|
| Immunity, Innate | 1 | 2002 | 226 | 0.040 |
Why?
|
| Prolactin | 4 | 1986 | 16 | 0.040 |
Why?
|
| Injections, Subcutaneous | 1 | 2000 | 60 | 0.040 |
Why?
|
| Neurosecretory Systems | 1 | 1999 | 10 | 0.040 |
Why?
|
| Research Design | 1 | 2001 | 184 | 0.040 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2019 | 14 | 0.040 |
Why?
|
| Nerve Fibers, Myelinated | 2 | 2010 | 22 | 0.040 |
Why?
|
| Sodium Chloride | 1 | 2000 | 65 | 0.040 |
Why?
|
| Phenylalanine | 2 | 1992 | 24 | 0.040 |
Why?
|
| Granuloma | 2 | 1977 | 18 | 0.040 |
Why?
|
| Sensorimotor Cortex | 1 | 2019 | 7 | 0.040 |
Why?
|
| Superoxide Dismutase-1 | 1 | 2019 | 51 | 0.040 |
Why?
|
| Rodentia | 1 | 2019 | 14 | 0.040 |
Why?
|
| Pulse Wave Analysis | 1 | 2019 | 29 | 0.040 |
Why?
|
| Heart Failure | 1 | 2002 | 249 | 0.040 |
Why?
|
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 2 | 2011 | 2 | 0.040 |
Why?
|
| Excitatory Amino Acid Agonists | 2 | 2011 | 5 | 0.040 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 2 | 1996 | 15 | 0.040 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2019 | 72 | 0.040 |
Why?
|
| Gyrus Cinguli | 1 | 1999 | 33 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2019 | 140 | 0.040 |
Why?
|
| Cell Line | 2 | 2012 | 696 | 0.040 |
Why?
|
| Carcinogenesis | 1 | 2019 | 81 | 0.040 |
Why?
|
| Fatty Acids | 1 | 2000 | 206 | 0.040 |
Why?
|
| Motor Skills | 1 | 1998 | 34 | 0.040 |
Why?
|
| Pattern Recognition, Visual | 1 | 1998 | 37 | 0.040 |
Why?
|
| Gonadotropin-Releasing Hormone | 3 | 1984 | 37 | 0.040 |
Why?
|
| Amyloidogenic Proteins | 1 | 2018 | 7 | 0.040 |
Why?
|
| Animals, Genetically Modified | 2 | 2009 | 54 | 0.040 |
Why?
|
| Polyploidy | 1 | 1977 | 12 | 0.040 |
Why?
|
| Muscle Development | 2 | 1997 | 9 | 0.040 |
Why?
|
| Complement C1 | 1 | 2017 | 3 | 0.040 |
Why?
|
| Parasympatholytics | 2 | 2011 | 13 | 0.040 |
Why?
|
| Cerebral Veins | 1 | 1997 | 11 | 0.030 |
Why?
|
| Granulation Tissue | 1 | 1977 | 7 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2017 | 51 | 0.030 |
Why?
|
| Emotions | 1 | 1998 | 133 | 0.030 |
Why?
|
| Calcium Channels | 1 | 1997 | 33 | 0.030 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2017 | 10 | 0.030 |
Why?
|
| Naloxone | 3 | 1981 | 19 | 0.030 |
Why?
|
| Matrix Metalloproteinases | 1 | 2017 | 31 | 0.030 |
Why?
|
| Acute-Phase Proteins | 1 | 1996 | 4 | 0.030 |
Why?
|
| PC12 Cells | 1 | 2016 | 22 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2019 | 612 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 1996 | 61 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2019 | 887 | 0.030 |
Why?
|
| Prostatic Neoplasms | 1 | 1999 | 277 | 0.030 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2017 | 67 | 0.030 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 2 | 1 | 1996 | 13 | 0.030 |
Why?
|
| Wound Healing | 1 | 1977 | 125 | 0.030 |
Why?
|
| Freund's Adjuvant | 1 | 1976 | 8 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 1 | 1996 | 97 | 0.030 |
Why?
|
| Protein Transport | 1 | 2016 | 158 | 0.030 |
Why?
|
| Purinergic P2Y Receptor Agonists | 1 | 2015 | 4 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 524 | 0.030 |
Why?
|
| Vibrissae | 1 | 2015 | 6 | 0.030 |
Why?
|
| Culture Techniques | 1 | 1995 | 12 | 0.030 |
Why?
|
| Quality of Life | 1 | 2020 | 487 | 0.030 |
Why?
|
| Glycation End Products, Advanced | 1 | 1995 | 17 | 0.030 |
Why?
|
| Maternal-Fetal Exchange | 1 | 1995 | 11 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2015 | 15 | 0.030 |
Why?
|
| Purinergic P2Y Receptor Antagonists | 1 | 2015 | 34 | 0.030 |
Why?
|
| Indomethacin | 1 | 2015 | 15 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 1999 | 356 | 0.030 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2015 | 13 | 0.030 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2015 | 26 | 0.030 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2015 | 25 | 0.030 |
Why?
|
| Polyribosomes | 1 | 1995 | 6 | 0.030 |
Why?
|
| Postural Balance | 1 | 2015 | 41 | 0.030 |
Why?
|
| Endothelium | 2 | 2010 | 28 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2014 | 9 | 0.030 |
Why?
|
| Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide | 1 | 2014 | 5 | 0.030 |
Why?
|
| Encephalitis | 1 | 2014 | 18 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2016 | 152 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2016 | 369 | 0.030 |
Why?
|
| CA3 Region, Hippocampal | 1 | 2014 | 3 | 0.030 |
Why?
|
| Vasoconstrictor Agents | 1 | 2014 | 34 | 0.030 |
Why?
|
| Synovial Membrane | 1 | 2014 | 13 | 0.030 |
Why?
|
| Blotting, Western | 2 | 1997 | 514 | 0.030 |
Why?
|
| Skin | 1 | 1995 | 149 | 0.030 |
Why?
|
| Pericytes | 1 | 2014 | 17 | 0.030 |
Why?
|
| Estrus | 3 | 1985 | 23 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2010 | 131 | 0.030 |
Why?
|
| Pharmaceutical Vehicles | 1 | 2014 | 7 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2014 | 56 | 0.030 |
Why?
|
| Young Adult | 1 | 2021 | 2733 | 0.030 |
Why?
|
| Haloperidol | 2 | 1986 | 8 | 0.030 |
Why?
|
| Protein Binding | 2 | 2011 | 658 | 0.030 |
Why?
|
| Bromodeoxyuridine | 2 | 2006 | 9 | 0.030 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 1993 | 3 | 0.030 |
Why?
|
| Receptor, Muscarinic M1 | 1 | 2013 | 5 | 0.030 |
Why?
|
| TRPC6 Cation Channel | 1 | 2013 | 6 | 0.030 |
Why?
|
| Serum Amyloid P-Component | 1 | 2013 | 9 | 0.030 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2013 | 31 | 0.030 |
Why?
|
| Vasodilator Agents | 1 | 2013 | 79 | 0.030 |
Why?
|
| Nogo Receptor 1 | 1 | 2013 | 1 | 0.030 |
Why?
|
| Rats, Inbred SHR | 1 | 2013 | 13 | 0.030 |
Why?
|
| Rats, Inbred WKY | 1 | 2013 | 13 | 0.030 |
Why?
|
| GPI-Linked Proteins | 1 | 2013 | 13 | 0.030 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 2013 | 1 | 0.030 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2013 | 18 | 0.030 |
Why?
|
| Morphine | 3 | 1981 | 29 | 0.030 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2013 | 33 | 0.030 |
Why?
|
| Caspase 8 | 1 | 2012 | 10 | 0.030 |
Why?
|
| Mice, Obese | 1 | 2012 | 21 | 0.030 |
Why?
|
| Dementia | 1 | 2014 | 94 | 0.030 |
Why?
|
| Organ Size | 1 | 1993 | 87 | 0.030 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 1992 | 13 | 0.030 |
Why?
|
| Tissue Survival | 1 | 2012 | 4 | 0.020 |
Why?
|
| Multiple Organ Failure | 1 | 2012 | 31 | 0.020 |
Why?
|
| Free Radical Scavengers | 1 | 2012 | 23 | 0.020 |
Why?
|
| Eating | 1 | 1993 | 70 | 0.020 |
Why?
|
| Chick Embryo | 1 | 2012 | 27 | 0.020 |
Why?
|
| Chimera | 1 | 2012 | 3 | 0.020 |
Why?
|
| Hydrolysis | 1 | 2012 | 60 | 0.020 |
Why?
|
| Tyrosine | 1 | 1992 | 92 | 0.020 |
Why?
|
| Gelatinases | 1 | 2012 | 14 | 0.020 |
Why?
|
| Seawater | 1 | 2012 | 42 | 0.020 |
Why?
|
| Myelin-Associated Glycoprotein | 1 | 2012 | 3 | 0.020 |
Why?
|
| Haplorhini | 1 | 2012 | 15 | 0.020 |
Why?
|
| Genistein | 2 | 2005 | 9 | 0.020 |
Why?
|
| Phenanthridines | 1 | 2012 | 12 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2012 | 114 | 0.020 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 2011 | 8 | 0.020 |
Why?
|
| Hominidae | 1 | 2012 | 11 | 0.020 |
Why?
|
| Culture Media, Conditioned | 1 | 2012 | 31 | 0.020 |
Why?
|
| GABA-A Receptor Antagonists | 1 | 2011 | 1 | 0.020 |
Why?
|
| Isotopes | 1 | 2011 | 10 | 0.020 |
Why?
|
| Bicuculline | 1 | 2011 | 4 | 0.020 |
Why?
|
| Pirenzepine | 1 | 2011 | 8 | 0.020 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2012 | 28 | 0.020 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2011 | 10 | 0.020 |
Why?
|
| Biophysics | 1 | 2011 | 14 | 0.020 |
Why?
|
| Genes, MHC Class II | 1 | 2011 | 10 | 0.020 |
Why?
|
| Receptors, AMPA | 1 | 2011 | 8 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 1991 | 74 | 0.020 |
Why?
|
| DNA Probes | 1 | 1991 | 13 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 133 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2011 | 60 | 0.020 |
Why?
|
| Lipoproteins, LDL | 1 | 2011 | 36 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2011 | 64 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1991 | 76 | 0.020 |
Why?
|
| Glycine | 1 | 2011 | 31 | 0.020 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 2011 | 12 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2013 | 247 | 0.020 |
Why?
|
| Vasculitis | 1 | 2011 | 13 | 0.020 |
Why?
|
| Tritium | 1 | 1991 | 17 | 0.020 |
Why?
|
| Secretory Rate | 2 | 1989 | 5 | 0.020 |
Why?
|
| Amygdala | 1 | 1991 | 52 | 0.020 |
Why?
|
| Trypsin | 1 | 1991 | 24 | 0.020 |
Why?
|
| Leucine | 1 | 1991 | 20 | 0.020 |
Why?
|
| Sirtuin 1 | 1 | 2011 | 41 | 0.020 |
Why?
|
| Endopeptidases | 1 | 1991 | 20 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 1991 | 62 | 0.020 |
Why?
|
| Estradiol | 2 | 1983 | 175 | 0.020 |
Why?
|
| Attention | 1 | 2011 | 90 | 0.020 |
Why?
|
| Acetylcysteine | 1 | 2011 | 24 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1991 | 168 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 1 | 2011 | 42 | 0.020 |
Why?
|
| Interleukins | 1 | 2012 | 112 | 0.020 |
Why?
|
| Retinal Vessels | 1 | 2011 | 72 | 0.020 |
Why?
|
| DNA, Circular | 1 | 1990 | 5 | 0.020 |
Why?
|
| Transducers, Pressure | 1 | 2010 | 2 | 0.020 |
Why?
|
| Carbachol | 1 | 2010 | 18 | 0.020 |
Why?
|
| Glutathione Synthase | 1 | 2010 | 4 | 0.020 |
Why?
|
| Glutathione Peroxidase | 1 | 2010 | 26 | 0.020 |
Why?
|
| Urinary Catheterization | 1 | 2010 | 15 | 0.020 |
Why?
|
| Muscle, Smooth | 1 | 2010 | 40 | 0.020 |
Why?
|
| Response Elements | 1 | 2010 | 22 | 0.020 |
Why?
|
| Cytoprotection | 1 | 2010 | 24 | 0.020 |
Why?
|
| GAP-43 Protein | 1 | 2010 | 1 | 0.020 |
Why?
|
| Schwann Cells | 1 | 2010 | 4 | 0.020 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2010 | 20 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 82 | 0.020 |
Why?
|
| Transcription Factor AP-1 | 1 | 2010 | 26 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2010 | 87 | 0.020 |
Why?
|
| Axons | 1 | 2010 | 24 | 0.020 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2010 | 25 | 0.020 |
Why?
|
| Polyethylene Glycols | 1 | 2011 | 101 | 0.020 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2010 | 69 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2010 | 82 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2010 | 86 | 0.020 |
Why?
|
| RNA Interference | 1 | 2010 | 137 | 0.020 |
Why?
|
| Femoral Artery | 1 | 2010 | 58 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 2010 | 69 | 0.020 |
Why?
|
| Thymidine Kinase | 1 | 2009 | 6 | 0.020 |
Why?
|
| Lateral Ventricles | 1 | 2009 | 8 | 0.020 |
Why?
|
| Myelin Sheath | 1 | 2009 | 27 | 0.020 |
Why?
|
| Vimentin | 1 | 2009 | 28 | 0.020 |
Why?
|
| Molecular Biology | 1 | 2009 | 17 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2009 | 57 | 0.020 |
Why?
|
| Muscle Denervation | 1 | 2009 | 2 | 0.020 |
Why?
|
| Myogenin | 1 | 2009 | 4 | 0.020 |
Why?
|
| Atherosclerosis | 1 | 2010 | 96 | 0.020 |
Why?
|
| Transgenes | 1 | 2009 | 63 | 0.020 |
Why?
|
| Adenoviridae | 1 | 2009 | 67 | 0.020 |
Why?
|
| Receptors, Nicotinic | 1 | 2009 | 10 | 0.020 |
Why?
|
| Logistic Models | 1 | 2010 | 407 | 0.020 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2009 | 41 | 0.020 |
Why?
|
| Viral Proteins | 1 | 2009 | 63 | 0.020 |
Why?
|
| Swine | 1 | 2009 | 236 | 0.020 |
Why?
|
| Kidney | 1 | 2010 | 286 | 0.020 |
Why?
|
| Pentobarbital | 1 | 1988 | 3 | 0.020 |
Why?
|
| Ditiocarb | 1 | 1988 | 6 | 0.020 |
Why?
|
| Immunization, Passive | 1 | 1988 | 20 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2009 | 233 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 281 | 0.020 |
Why?
|
| Alcohol Drinking | 1 | 1989 | 167 | 0.020 |
Why?
|
| Dexamethasone | 1 | 1987 | 63 | 0.020 |
Why?
|
| Somatostatin-28 | 1 | 1986 | 1 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2006 | 44 | 0.020 |
Why?
|
| Potassium | 1 | 1986 | 42 | 0.020 |
Why?
|
| Radiation Dosage | 1 | 2006 | 54 | 0.020 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2006 | 4 | 0.020 |
Why?
|
| Fenclonine | 1 | 1986 | 1 | 0.020 |
Why?
|
| Piribedil | 1 | 1986 | 1 | 0.020 |
Why?
|
| Thyrotropin-Releasing Hormone | 1 | 1986 | 12 | 0.020 |
Why?
|
| Pilocarpine | 1 | 1986 | 8 | 0.020 |
Why?
|
| Naltrexone | 1 | 1986 | 19 | 0.020 |
Why?
|
| Exercise | 1 | 2010 | 479 | 0.020 |
Why?
|
| Tail | 1 | 2005 | 4 | 0.020 |
Why?
|
| Androstadienes | 1 | 2005 | 3 | 0.020 |
Why?
|
| Piperazines | 1 | 1986 | 47 | 0.020 |
Why?
|
| Gonadal Steroid Hormones | 1 | 1985 | 24 | 0.020 |
Why?
|
| Leptin | 1 | 2005 | 67 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2005 | 79 | 0.010 |
Why?
|
| Policy Making | 1 | 2004 | 13 | 0.010 |
Why?
|
| Receptors, LHRH | 1 | 1984 | 17 | 0.010 |
Why?
|
| beta-Endorphin | 4 | 1985 | 5 | 0.010 |
Why?
|
| Heart Rate | 1 | 2005 | 379 | 0.010 |
Why?
|
| Narcotic Antagonists | 1 | 1983 | 32 | 0.010 |
Why?
|
| Catecholamines | 1 | 1982 | 18 | 0.010 |
Why?
|
| Periodicity | 1 | 1982 | 17 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2002 | 94 | 0.010 |
Why?
|
| Nephritis, Interstitial | 1 | 1982 | 2 | 0.010 |
Why?
|
| Progesterone | 1 | 1983 | 129 | 0.010 |
Why?
|
| Benzilates | 1 | 1981 | 1 | 0.010 |
Why?
|
| Methyltyrosines | 1 | 1981 | 1 | 0.010 |
Why?
|
| alpha-Methyltyrosine | 1 | 1981 | 1 | 0.010 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 1981 | 7 | 0.010 |
Why?
|
| Methyldopa | 1 | 1981 | 1 | 0.010 |
Why?
|
| Quipazine | 1 | 1981 | 1 | 0.010 |
Why?
|
| Clonidine | 1 | 1981 | 10 | 0.010 |
Why?
|
| Rabbits | 2 | 1983 | 277 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2002 | 288 | 0.010 |
Why?
|
| Lactation | 1 | 1981 | 61 | 0.010 |
Why?
|
| Quinolines | 1 | 1981 | 25 | 0.010 |
Why?
|
| Mossy Fibers, Hippocampal | 1 | 2001 | 1 | 0.010 |
Why?
|
| Pituitary Hormones, Anterior | 1 | 1981 | 10 | 0.010 |
Why?
|
| Antimetabolites | 1 | 2001 | 5 | 0.010 |
Why?
|
| Biotransformation | 1 | 1981 | 9 | 0.010 |
Why?
|
| Gonads | 1 | 1981 | 7 | 0.010 |
Why?
|
| Enkephalins | 1 | 1980 | 6 | 0.010 |
Why?
|
| Membrane Fluidity | 1 | 2000 | 5 | 0.010 |
Why?
|
| Litter Size | 1 | 1980 | 12 | 0.010 |
Why?
|
| Kinetics | 1 | 1981 | 545 | 0.010 |
Why?
|
| Autoimmune Diseases | 1 | 1982 | 164 | 0.010 |
Why?
|
| Parity | 1 | 1980 | 49 | 0.010 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2000 | 62 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2000 | 175 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2001 | 407 | 0.010 |
Why?
|
| Achilles Tendon | 1 | 1977 | 2 | 0.010 |
Why?
|
| Photometry | 1 | 1977 | 3 | 0.010 |
Why?
|
| Seminal Vesicles | 1 | 1977 | 5 | 0.010 |
Why?
|
| Isoflavones | 1 | 1997 | 8 | 0.010 |
Why?
|
| Calcium Channels, L-Type | 1 | 1997 | 8 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 1997 | 62 | 0.010 |
Why?
|
| Connective Tissue | 1 | 1977 | 4 | 0.010 |
Why?
|
| Thymus Gland | 1 | 1977 | 54 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 1997 | 73 | 0.010 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 1997 | 50 | 0.010 |
Why?
|
| Exudates and Transudates | 1 | 1977 | 11 | 0.010 |
Why?
|
| Lectins | 1 | 1996 | 13 | 0.010 |
Why?
|
| Gliosis | 1 | 1996 | 17 | 0.010 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 1996 | 21 | 0.010 |
Why?
|
| Colchicine | 1 | 1996 | 16 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 1996 | 36 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1976 | 20 | 0.010 |
Why?
|
| Phagocytes | 1 | 1976 | 15 | 0.010 |
Why?
|
| Cytotoxins | 1 | 1996 | 51 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1997 | 259 | 0.010 |
Why?
|
| Arginine | 1 | 1995 | 42 | 0.010 |
Why?
|
| Blood Proteins | 1 | 1995 | 68 | 0.010 |
Why?
|
| Lysine | 1 | 1995 | 74 | 0.010 |
Why?
|
| Base Sequence | 1 | 1996 | 586 | 0.010 |
Why?
|
| Polymers | 1 | 1976 | 117 | 0.010 |
Why?
|
| Corticotropin-Releasing Hormone | 2 | 1985 | 28 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1996 | 1054 | 0.010 |
Why?
|
| Thyrotropin | 1 | 1986 | 11 | 0.000 |
Why?
|
| Feedback | 1 | 1985 | 33 | 0.000 |
Why?
|
| Estrogens | 1 | 1985 | 56 | 0.000 |
Why?
|
| Pituitary Gland, Posterior | 1 | 1983 | 1 | 0.000 |
Why?
|
| Hypothalamus, Anterior | 1 | 1983 | 1 | 0.000 |
Why?
|
| Hypothalamus, Middle | 1 | 1983 | 1 | 0.000 |
Why?
|
| Cell Fusion | 1 | 1982 | 7 | 0.000 |
Why?
|
| Thymidine | 1 | 1982 | 7 | 0.000 |
Why?
|
| History, 20th Century | 1 | 1981 | 84 | 0.000 |
Why?
|
| Enkephalin, Methionine | 1 | 1980 | 2 | 0.000 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 1980 | 19 | 0.000 |
Why?
|
| Pituitary-Adrenal System | 1 | 1980 | 20 | 0.000 |
Why?
|